MCM
UTHR icon

Moore Capital Management’s United Therapeutics UTHR Stock Holding History

Moore Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-89,979
Closed -$18.8M – 657
2022
Q3 		$18.8M Buy
89,979
+15,890
+21% +$3.55M 0.52% 40
2022
Q2 		$17.5M Buy
74,089
+401
+0.5% +$81.5K 0.53% 38
2022
Q1 		$13.2M Buy
73,688
+4,859
+7% +$926K 0.43% 53
2021
Q4 		$14.9M Sell
68,829
-49,486
-42% -$9.71M 0.38% 67
2021
Q3 		$21.8M Buy
118,315
+29,623
+33% +$5.83M 0.44% 65
2021
Q2 		$15.9M Buy
+88,692
New +$16.9M 0.29% 95
2015
Q2 		– Sell
-6,000
Closed -$1.03M – 548
2015
Q1 		$1.03M Buy
+6,000
New +$915K 0.04% 353

Other funds holding UTHR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return